Loading organizations...
The UConn Innovation Fund operates as a vital resource for commercializing innovations stemming from the University of Connecticut's research ecosystem. It offers financial support, up to $100,000, to projects demonstrating high potential for market entry and societal impact. This initiative bridges the critical gap between academic discovery and practical application, providing necessary capital for proof-of-concept, prototype development, and early-stage commercialization activities.
The fund originated through a collaborative effort involving the University of Connecticut, Webster Bank, and Connecticut Innovations. Established with a $1.5 million commitment over a two-year period, it reflects a strategic partnership designed to foster economic development within the state by leveraging university intellectual property. This foundational insight recognized the latent value within academic research and the need for dedicated funding mechanisms to unlock its commercial potential.
The primary beneficiaries of the UConn Innovation Fund are university innovators, including faculty, staff, and students, who are developing novel technologies and solutions. The fund aims to accelerate the transition of these promising discoveries from the laboratory to the marketplace, nurturing a vibrant entrepreneurial culture within the institution. Its long-term vision is to drive economic growth and job creation by transforming UConn's intellectual assets into successful enterprises.
UCONN Innovation Fund has 1 tracked investment across 1 company. The latest tracked deal is $13.0M Series A in Torigen Pharmaceuticals in November 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 17, 2022 | Torigen Pharmaceuticals | $13.0M Series A | Connecticut Innovations, Musan Duric | Advantage Capital, Neil Cohen, Gaingels, Ironwood Capital, Kema Fund, SoGal Ventures, University OF Notre Dame |